Both ICAM-1 and B7.1 are required to convert non-stimulatory keratinocytes into T cell-stimulating APCs

European Journal of Dermatology

Volumn 7, Issue 7, 1997, Pages 481-486

  Alamartine, Eric ^a   Stauss, Hans J ^b   Beverley, Peter C L ^c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

B7; Costimulation; ICAM 1; Keratinocytes

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KERATINOCYTE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030728250     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. VonKnebel-Doeberitz M. Papillomoviruses in human disease: pathogenesis and epidemiology of human papillomavirus infections. Eur J Med 1992; 1: 415-23.
2. VonKnebel-Doeberitz M. Papillomaviruses in human disease: molecular biology and immunology of papillomavirus infections and carcinogenesis. Eur J Med 1992; 1: 485-91.
3. Hawley-Nelson CC, Voudsen KH, Hubbert NL, Lowy D, Schiller JT. HPV-16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes EMBO J 1988; 8: 3905-10.
4. Munger K, Phleps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1988; 63: 4417-21.
5. Hudson JB, Bedell MA, McCance D, Lailins LA. Immortalization and altered differentiation of human keratinocytes in vitro by E6 and E7 open reading frames of human papillomavirus type 18. J Virol 1990; 64: 519-26.
6. Schafer A, Friemann W, Mielke M, Schawrlander B Koch MA. The increased frequency of cervical dysplasia in women with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynaecol 1991; 164: 593-9.
7. Scheil AGR. Development of malignancy following renal transplantation in Australia and New Zeland. Transplant Proc 1992; 24: 1275-9.
8. Altmann A, Jochmus-Kudielka I, Rainer F, et al. Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur J Immunol 1992; 28: 326-33.
9. Kast WM, Brandt RM, Drijhuoft JW, Melief CJ. Human leukocyte anitgen- A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J Immunother 1993; 14: 115-20.
10. Strang G. Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 1990; 71: 423-31.
11. Wank R, Meulen JT, Luande J, Eberhardt HC, Pawlita M. Cervical intraepithelial neoplasla, cervical carcinoma and risk for patients with HLA- DQB1 *0602, *0301, *0303 alleles. Lancet 1993; 341: 1215.
12. Simon JC, Cruz PD, Bergstressar PR, Davis LG, Tigelaar RE. Phorbol myristate acetate activated keratinocytes stimulate proliferation of resting peripheral blood mononuclear lymphocytes via a MHC-inaependent but protein kinase C and inter- cellular adhesion molecule-dependent mechanism. J Immunol 1991; 146: 476.
13. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation). Eur J Immunol 1994; 24: 859-66.
14. Bal V, McIndoe A, Denton G, et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990; 20: 1893-7.
15. Gaspari AA, Jenkins MK, Katz SI. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol 1988; 141: 2216-20.
16. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigenic presentation and induces B7 expression. Nature 1992; 360: 266-8.
17. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15 (7): 321-31.
18. Gimmi CD, Freeman GJ, Gribben JH, Gray G, Nadler LM. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Narf Acad Sci USA 1993; 90: 6586-90.
19. Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T cell interactions with keratinocytes. Immunol Today 1994; 15: 464-9.
20. Augustin M, Dietrich A, Nieder R, et al. Phorbol-12-Myristate-13-Acetate- treated human keratinocytes express B7-like molecules that serve a costimulatory role in T cell activation. J Invest Dermatol 1993; 100: 275-81.
21. Nickoloff BJ, Mitra RS, Lee K, et al. Discordant expression of CD28 ligands BB-1, ana B7 on keratinocytes in vitro and psoriatic cells. Am J Pathol 1993; 142: 1029-40.
22. Nickoloff BJ, Basham TY, Merigan TC, Morhenn VB. Keratinocyte class II histocompatibility antigen expression. Br J Dermatol 1985; 112: 373.
23. Griffiths CEM, Voorhees JJ, Nickoloff BJ. Gamma Interferon induced different cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-1 antigens. Br J Dermatol 1989; 120: 1.
24. Nickoloff BJ, Mitra RS, Green J, et al. Accessory cell function of keratinocytes for superantigens: dependence on lymphocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. J Immunol 1993; 150: 2148-59.
25. Symington FW, Santos EB. Lysis of human keratinocytes by allogenic HLA class 1-specific cytotoxic T cells: keratinocytes ICAM-1 (CD54] and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-g-treated keratinocytes. J Immunology 1991; 146: 2169-75.
26. Azuma M, Cayabyab C, Buck B, Phillips JH, Lanier JJ. CD28 interaction with B7 costimulates primary allogenic proliferative responses and cytotoxicity mediated by small reting T lymphocytes. J Exp Med 1992; 175: 353-60.
27. Hording FA, Allison JP. CD28-B7 interactions allow the induction of CD8 cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993; 177: 1791-6.
28. Van Gool SW, de Boer M, Ceuppens JL. CD28 liqation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J Immunology 1993; 150: 3254-63.
29. Lanier LL, O'Fallon S, Somoza C, et al. CD80(B7) and CD86(B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154: 97-105.